B7.1 and B7.2 co-stimulatory molecules regulate crescentic glomerulonephritis

Area of Science:

• Immunology
• Nephrology
• Cell Biology

Background:

• Crescentic glomerulonephritis (GN) is a severe kidney disease characterized by rapid glomerular injury.
• T cell-mediated immune responses and co-stimulatory molecules play critical roles in GN pathogenesis.
• The specific contributions of B7.1 and B7.2 co-stimulation in GN remain incompletely understood.

Purpose of the Study:

• To investigate the distinct roles of B7.1 and B7.2 co-stimulatory molecules in a murine model of crescentic GN.
• To determine the impact of blocking B7.1 or B7.2 on T cell accumulation and renal injury.
• To elucidate the co-stimulatory molecule involvement in Th1-directed, cell-mediated renal injury.

Main Methods:

• A murine model of crescentic GN was induced using a "planted" antigen.
• Mice were treated with anti-B7.1 or anti-B7.2 monoclonal antibodies (mAbs) or control antibodies.
• Renal injury was assessed by glomerular crescent formation, T cell infiltration, proteinuria, antibody titers, and delayed type hypersensitivity.

Main Results:

• Anti-B7.2 mAb treatment exacerbated renal injury, increasing crescent formation, T cell infiltration, and proteinuria.
• Anti-B7.1 mAb treatment reduced crescent formation but did not significantly alter T cell accumulation or proteinuria.
• Anti-B7.1 mAb treatment was more effective in reducing renal injury parameters compared to anti-B7.2 mAb treatment.

Conclusions:

• B7.1 and B7.2 co-stimulatory molecules are crucial in crescentic GN pathogenesis.
• These molecules exert opposing effects on disease development, with B7.1 being protective and B7.2 detrimental.
• The observed effects occur independently of alterations in T helper cell subset responses or antibody production.